6505--PET MRI Radiopharmaceuticals, Detroit

This award contracts SOFIE Co. to supply a full suite of PET‑MRI radiopharmaceuticals—Cu‑64 Dotatate (Detectnet), F‑18 PSMA (Pylarify), F‑18 FDG, and F‑18 Neuraceq—along with associated packaging, transport, manifests, and reporting for the John D. Dingell VA Medical Center in Detroit, MI. The procurement is a sole‑source, firm‑fixed‑price purchase order valued at approximately $558 k for a twelve‑month performance period. The VA determined that no other vendor could provide the complete set of required agents, justifying the “only one responsible source” determination. • Scope: supply, package, ship, and report on four FDA‑approved radiopharmaceuticals, plus cancellation‑fee items. • Value: $557,676.73 (award) – $560,233.85 (estimated) – firm‑fixed‑price. • Performance period: 1 Oct 2026 – 30 Sep 2027, delivery to Detroit, MI.